The Trump administration's move to end subsidies for Medicare drug plans could cost consumers

The Trump administration's decision to eliminate federal subsidies for Medicare drug plans will likely lead to higher premiums for millions of beneficiaries starting in 2027. This move could significantly increase out-of-pocket costs for seniors relying on these plans, putting a financial strain on an already vulnerable population. The change underscores the potential long-term impacts of policy decisions on everyday Americans' healthcare expenses, highlighting a critical issue in ongoing debates about healthcare affordability and government support.